Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 8, Issue 1 (2019)

Antihyperlipidemic activity of Commiphora mukul: A review

Author(s):
Mohammad Anas, Ziaur Rahman and Tanzeel Ahmad
Abstract:
Disorders of lipoprotein metabolism are collectively referred to as “Dyslipidemias”. Most of the Dyslipidemias are Hyperlipidemias Cardiovascular disease is the leading cause of morbidity and mortality world-wide, which is an important risk factor for cardiovascular diseases. Therapies aimed at lipid modification are important for the reduction of cardiovascular risk. Pharmacological management in conventional medicine includes statins and fibrates or both. The statins and fibrates have side effects such as myalgia, myositis, rhabdomyolysis, dyspepsia, renal failure and cholelithiasis etc. In Unani medicine a large number of single and compound drugs are being used in the treatment of Obesity. Experimental and clinical studies of some of these drugs revealed hypolipidemic, antioxidant and cardioprotective properties This review discusses the antihyperlipidemic activities of the Commiphora mukul.
Pages: 496-498  |  538 Views  109 Downloads


The Pharma Innovation Journal
How to cite this article:
Mohammad Anas, Ziaur Rahman, Tanzeel Ahmad. Antihyperlipidemic activity of <em>Commiphora mukul</em>: A review. Pharma Innovation 2019;8(1):496-498.

Call for book chapter